Susquehanna International Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Susquehanna International Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,600	Closed	-$67K	–	12994
2022 Q3	$67K	Sell	16,600 -2,200	-12%	-$16.7K	﹤0.01%	12013
2022 Q2	$212K	Sell	18,800 -18,500	-50%	-$222K	﹤0.01%	10491
2022 Q1	$606K	Buy	37,300 +30,300	+433%	+$776K	﹤0.01%	8459
2021 Q4	$332K	Sell	7,000 -22,200	-76%	-$1.33M	﹤0.01%	10230
2021 Q3	$2.12M	Sell	29,200 -400	-1%	-$28.9K	﹤0.01%	5703
2021 Q2	$2.48M	Buy	+29,600	New	+$1.95M	﹤0.01%	5431

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group's NBP Position: Q1 2026 in Review

Susquehanna International Group reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 73% in Q1 2026, selling an estimated $116K and leaving 12,817 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12753.

Susquehanna International Group first reported a position in NBP in Q2 2021 and has held it in 14 quarters since. The position peaked at $922K in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Susquehanna International Group held 12,817 shares of NovaBridge Biosciences American Depositary Shares worth $31.5K as of Q1 2026.
Susquehanna International Group sold 34,662 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $116K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12753 holding.
Susquehanna International Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 14 quarters since.
Susquehanna International Group's NovaBridge Biosciences American Depositary Shares position peaked at $922K in Q2 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.